Waymark

Waymark is a Medicaid provider-enablement company founded in 2021 as a Public Benefit Corporation. It aims to improve healthcare access and outcomes for Medicaid beneficiaries by empowering existing primary care providers with technology-enabled, community-based care teams. Waymark partners with Medicaid Managed Care Organizations (MCOs) to deliver evidence-based interventions that are highly effective but rarely available to Medicaid patients.

Waymark's approach involves deploying local teams comprising community health workers, pharmacists, social workers, and medical assistants to collaborate with primary care practices. These teams are supported by Waymark Signal, a proprietary machine learning technology that identifies patients at risk of avoidable healthcare utilization and guides the teams toward appropriate interventions. Waymark designs its technology and services for underserved communities, promoting healthcare access regardless of language barriers, technology usage, or trust in traditional care delivery models.

As of January 2023, Waymark supported approximately 50,000 Medicaid members across Washington state and Virginia. The company has secured partnerships with major health systems like Providence, federally qualified health centers like Country Doctor Community Health Center, and independent practices in these markets. Early results show improvements in quality scores, reduced non-emergent emergency department visits, and fewer hospitalizations.

Key customers and partnerships

Waymark has formed strategic partnerships with several healthcare organizations to expand its reach and impact. For instance, the company works closely with Providence, one of the largest health systems in the country, to enhance access to care for Medicaid patients. Additionally, Waymark collaborates with Country Doctor Community Health Center, a Seattle-based federally qualified health center, aligning with the center's mission and values to provide whole-person care tailored to the needs of its Medicaid patient population.